New cancer clinical trial: Study to Evaluate the Safety, Tolerability,Pharmacokinetics, and Anti-tumor Activity of a Thorium-227 Labeled Antibody-chelator Conjugate, in Patients With Metastatic Castration Resistant Prostate Cancer

Published on: October 30, 2018 at 09:30PM

• Tweet
• Share
• Share
• Share
• Share